Literature DB >> 23724526

Ondansetrone or metoclopromide? Which is more effective in severe nausea and vomiting of pregnancy? A randomized trial double-blind study.

Mehrdad Kashifard1, Zahra Basirat, Maede Kashifard, Masoumeh Golsorkhtabar-Amiri, Aliakbar Moghaddamnia.   

Abstract

BACKGROUND: Nausea and vomiting of pregnancy (NVP) are seen in 50-80% of pregnancies. However, in severe NVP, called hypermesis gravidarum (HG), medical therapy to reduce nausea and vomiting is inevitable and ondansetron (OND) as an effective drug has recently been proposed. This study evaluated the effectiveness of OND versus metoclopramide (MET) in the treatment of HG.
METHODS: In this clinical trial study, 83 pregnant women with HG were enrolled in 2011-2012 and randomly divided in two groups. The first group received oral administration of MET and the second group was treated with OND for two weeks. Severity of nausea and vomiting were evaluated according to visual analogue scale (VAS) criteria. Data analysis was done by chi2, Fisher exact test and Student's t-test.
RESULTS: Comparison of the trend of change of vomiting in the two groups during the 14-day treatment showed the OND group had significantly lower vomiting scores versus the MET group (p = 0.042), while there was no significant difference in the trend of nausea.
CONCLUSION: OND has a more favorable effect in controlling severe vomiting.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23724526

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  9 in total

Review 1.  Treatment options for hyperemesis gravidarum.

Authors:  Amy Abramowitz; Emily S Miller; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2017-01-09       Impact factor: 3.633

2.  From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2017-06-02       Impact factor: 3.199

Review 3.  Nausea and vomiting of pregnancy - What's new?

Authors:  Martha Bustos; Raman Venkataramanan; Steve Caritis
Journal:  Auton Neurosci       Date:  2016-05-13       Impact factor: 3.145

Review 4.  Nausea and vomiting in early pregnancy.

Authors:  Mario Festin
Journal:  BMJ Clin Evid       Date:  2014-03-19

Review 5.  Barriers and Challenges in Hyperemesis Gravidarum Research.

Authors:  Iris J Grooten; Tessa J Roseboom; Rebecca C Painter
Journal:  Nutr Metab Insights       Date:  2016-02-14

Review 6.  Supportive medication in cancer during pregnancy.

Authors:  Flora Zagouri; Nikolaos Dedes; Alkistis Papatheodoridi; Michael Liontos; Meletios Athanasios Dimopoulos
Journal:  BMC Pregnancy Childbirth       Date:  2020-12-01       Impact factor: 3.007

Review 7.  Emerging Progress in Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum: Challenges and Opportunities.

Authors:  Chuan Liu; Guo Zhao; Danni Qiao; Lintao Wang; Yeling He; Mingge Zhao; Yuanyuan Fan; Enshe Jiang
Journal:  Front Med (Lausanne)       Date:  2022-01-10

8.  Ondansetron versus metoclopramide for managing hyperemesis gravidarum: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Ebraheem Albazee; Lina Almahmoud; Firas Al-Rshoud; Dima Sallam; Wardah Albzea; Rawan Alenezi; Saeed Baradwan; Ahmed Abu-Zaid
Journal:  Turk J Obstet Gynecol       Date:  2022-06-27

9.  Validating the effect of Ondansetron and Mirtazapine In Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial.

Authors:  Anne Ostenfeld; Tonny Studsgaard Petersen; Tina Bergmann Futtrup; Jon Trærup Andersen; Andreas Kryger Jensen; Hanne Brix Westergaard; Lars Henning Pedersen; Ellen Christine Leth Løkkegaard
Journal:  BMJ Open       Date:  2020-03-24       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.